Cargando…

A case report of thalidomide in the treatment of camrelizumab-induced reactive cutaneous capillary hyperplasia

Reactive cutaneous capillary endothelial proliferation (RCCEP) is the most prevalent immune-related adverse event observed in patients undergoing camrelizumab treatment, and there is a lack of effective therapeutic strategies. Thalidomide (THD) has anti-inflammatory, immunomodulatory, antiangiogenic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fu, Shujuan, Li, Cunya, Wang, Zhiying, Zhong, Zhixian, Zhong, Yi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10313310/ https://www.ncbi.nlm.nih.gov/pubmed/37390264 http://dx.doi.org/10.1097/MD.0000000000034120

Ejemplares similares

Thalidomide for prevention of camrelizumab‐induced reactive cutaneous capillary endothelial proliferation
por: Song, Geng, et al.
Publicado: (2022)

The whole treatment process and thinking of a patient with NUT carcinoma of the parotid gland: a case report
por: Fu, Shujuan, et al.
Publicado: (2023)

Reactive Cutaneous Capillary Endothelial Proliferation Caused by Camrelizumab: Sixteen Case Reports
por: Hui-Mei, Pang, et al.
Publicado: (2023)

Anlotinib improved the reactive cutaneous capillary endothelial proliferation induced by camrelizumab: a case report
por: Wu, Rui, et al.
Publicado: (2022)

Predicting Outcome in Combination Treatment of TACE and Camrelizumab for Advanced Hepatocellular carcinoma: Tumor Hypervascularity and Reactive Cutaneous Capillary Endothelial Proliferation
por: Yin, Liang, et al.
Publicado: (2022)

Sustained remission of recalcitrant cutaneous lymphoid hyperplasia after thalidomide treatment
por: Erickson, Stephen P., et al.
Publicado: (2018)

Reactive cutaneous capillary endothelial proliferation predicted the efficacy of camrelizumab in patients with recurrent/metastatic head and neck squamous cell carcinoma
por: Ding, Qi, et al.
Publicado: (2023)

Case report: A case of acute mastitis associated with reactive cutaneous capillary endothelial proliferation after camrelizumab treatment: A new immune-related adverse event
por: Wu, Ping-Shang, et al.
Publicado: (2022)

Nasal alar metastasis of advanced hepatocellular carcinoma misdiagnosed as reactive cutaneous capillary endothelial proliferation in a patient treated with camrelizumab and apatinib: a case report
por: Liu, Jin, et al.
Publicado: (2023)

Emerging Treatments for Reactive Cutaneous Capillary Endothelial Proliferation
por: Liu, Yi, et al.
Publicado: (2023)

Reactive cutaneous capillary endothelial proliferation in advanced hepatocellular carcinoma patients treated with camrelizumab: data derived from a multicenter phase 2 trial
por: Wang, Feng, et al.
Publicado: (2020)

Sintilimab treatment for ureteral carcinoma following bladder cancer leads to leukopenia: a case report
por: Zhong, Zhixian, et al.
Publicado: (2022)

Thalidomide—Then and Now: Case Report of a Woman With Thalidomide Embryopathy and Review of Current Thalidomide Uses
por: Malik, Sara, et al.
Publicado: (2021)

Immune-Related Colitis Induced by Camrelizumab: A Case Report
por: Cheng, Sheng, et al.
Publicado: (2023)

Successful response to camrelizumab in metastatic bladder cancer: A case report
por: Xie, Chen, et al.
Publicado: (2022)

Death and Rebirth of the Thalidomide Molecule: A Case of Thalidomide-Induced Sensory Neuropathy
por: Kesserwani, Hassan
Publicado: (2021)

Camrelizumab for the treatment of advanced cervical adenocarcinoma: a case report and literature review
por: Zhang, Lei, et al.
Publicado: (2022)

Case Report: Successful treatment of advanced hepatocarcinoma with the PD-1 inhibitor Camrelizumab
por: Ye, Wenling, et al.
Publicado: (2023)

Rethinking thalidomide.
Publicado: (1995)

Thalidomide and neurotrophism
por: Soper, Judith R., et al.
Publicado: (2018)

Thalidomide‐induced teratogenesis: History and mechanisms
por: Vargesson, Neil
Publicado: (2015)

Successful treatment with thalidomide for pemphigus vulgaris
por: Zhang, Bingjie, et al.
Publicado: (2020)

Clinical Complete Remission of An Advanced Gastric Adenocarcinoma After Camrelizumab Plus Chemotherapy Followed by Camrelizumab Plus Capecitabine: A Case Report
por: Lin, Jieheng, et al.
Publicado: (2021)

Efficacy of Drug-Eluting Beads Transarterial Chemoembolization Plus Camrelizumab Compared With Conventional Transarterial Chemoembolization Plus Camrelizumab for Unresectable Hepatocellular Carcinoma
por: Ren, Yanqiao, et al.
Publicado: (2022)

Case report: Camrelizumab associated with central retinal vein occlusion
por: Zhan, Yixiang, et al.
Publicado: (2022)

Transarterial chemoembolization combined with camrelizumab for recurrent hepatocellular carcinoma
por: Guo, Yusheng, et al.
Publicado: (2022)

Efficacy and Safety of Thalidomide for Chemotherapy-induced Nausea and Vomiting
por: Wang, Nan, et al.
Publicado: (2020)

Thalidomide in Dermatology: Revisited
por: Hassan, Iffat, et al.
Publicado: (2015)

Thalidomide and its analogues in the treatment of Multiple Myeloma
por: Latif, Tahir, et al.
Publicado: (2012)

Scleromyxedema without Paraproteinemia: Treatment with Thalidomide and Prednisolone
por: Saniee, Sara, et al.
Publicado: (2016)

Thalidomide as an effective treatment for adult multiple xanthogranuloma
por: Debois, Deborah, et al.
Publicado: (2018)

Thalidomide for the Treatment of Refractory Multiple Myeloma: Association of Plasma Concentrations of Thalidomide and Angiogenic Growth Factors with Clinical Outcome
por: Kakimoto, Tsunayuki, et al.
Publicado: (2002)

High-dose thalidomide increases the risk of peripheral neuropathy in the treatment of ankylosing spondylitis
por: Xue, Hong-xia, et al.
Publicado: (2015)

Thalidomide-induced sinus bradycardia in Crohn’s disease: case report and literature review
por: Liu, Menghui, et al.
Publicado: (2019)

Purely cutaneous Langerhans cell histiocytosis presenting as an ulcer on the chin in an elderly man successfully treated with thalidomide
por: Subramaniyan, Radhakrishnan, et al.
Publicado: (2015)

Successful treatment of metastatic hepatic epithelioid hemangioendothelioma with thalidomide: a case report
por: Raphael, Claire, et al.
Publicado: (2010)

Thalidomide combined with endoscopy in the treatment of Cronkhite-Canada syndrome: A case report
por: Rong, Jia-Mei, et al.
Publicado: (2022)

Reactive lymphoid hyperplasia of the liver: A case report
por: Zhang, Wenyan, et al.
Publicado: (2019)

Thalidomide-induced heart block in a dialysis patient
por: Anwar, Siddiq, et al.
Publicado: (2009)

Inhibition of 13-cis retinoic acid-induced gene expression of reactive-resistance genes by thalidomide in glioblastoma tumours in vivo
por: Milanovic, Dusan, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_tqtij249aueuvgo1fabkb2mbji